FNY Managed Accounts’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$2K Sell
3
-1
-25% -$1.1K ﹤0.01% 458
2017
Q4
$3K Sell
4
-18
-82% -$16.6K ﹤0.01% 481
2017
Q3
$24K Buy
+22
New +$25K 0.03% 311
2016
Q4
Sell
-135
Closed -$54K 317
2016
Q3
$54K Buy
+135
New +$55.1K 0.05% 201

Other funds holding HSTO

FNY Managed Accounts's HSTO Position: Q1 2018 in Review

FNY Managed Accounts reduced its Histogen Inc. Common Stock (HSTO) stake by 25% in Q1 2018, selling an estimated $1.1K and leaving 3 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #458.

FNY Managed Accounts first reported a position in HSTO in Q3 2016 and has held it in 4 quarters since. The position peaked at $54K in Q3 2016. 73 funds tracked by Wall St. Rank hold HSTO as of Q1 2018.

  • FNY Managed Accounts held 3 shares of Histogen Inc. Common Stock worth $2K as of Q1 2018.
  • FNY Managed Accounts sold 1 Histogen Inc. Common Stock share in Q1 2018, an estimated $1.1K.
  • Histogen Inc. Common Stock made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #458 holding.
  • FNY Managed Accounts first reported a position in Histogen Inc. Common Stock in Q3 2016 and has held it in 4 quarters since.
  • FNY Managed Accounts's Histogen Inc. Common Stock position peaked at $54K in Q3 2016.
  • 73 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.